JW LIFESCIENCE (234080) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, JW LIFESCIENCE (234080) reported revenue of 257.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025257.8 billion KRW33.2 billion KRW28.6 billion KRW[source]
2024222.5 billion KRW35.9 billion KRW44.0 billion KRW[source]
2023206.9 billion KRW30.9 billion KRW28.1 billion KRW[source]
2022188.9 billion KRW27.1 billion KRW15.0 billion KRW[source]
2021169.8 billion KRW28.4 billion KRW12.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025297.4 billion KRW89.4 billion KRW208.0 billion KRW[source]
2024295.7 billion KRW106.2 billion KRW189.6 billion KRW[source]
2023252.4 billion KRW98.1 billion KRW154.3 billion KRW[source]
2022254.3 billion KRW113.2 billion KRW141.2 billion KRW[source]
2021216.0 billion KRW87.4 billion KRW128.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice